187 related articles for article (PubMed ID: 23424118)
1. Identifying master regulators of cancer and their downstream targets by integrating genomic and epigenomic features.
Gevaert O; Plevritis S
Pac Symp Biocomput; 2013; ():123-34. PubMed ID: 23424118
[TBL] [Abstract][Full Text] [Related]
2. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
Zhang J; Zhang S; Wang Y; Zhang XS
BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
[TBL] [Abstract][Full Text] [Related]
3. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
4. Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
Kundu S; Cheng Y; Shin M; Manyam G; Mallick BK; Baladandayuthapani V
PLoS One; 2018; 13(7):e0195070. PubMed ID: 30059495
[TBL] [Abstract][Full Text] [Related]
5. MethCNA: a database for integrating genomic and epigenomic data in human cancer.
Deng G; Yang J; Zhang Q; Xiao ZX; Cai H
BMC Genomics; 2018 Feb; 19(1):138. PubMed ID: 29433427
[TBL] [Abstract][Full Text] [Related]
6. A Systemic Analysis of Transcriptomic and Epigenomic Data To Reveal Regulation Patterns for Complex Disease.
Xu C; Zhang JG; Lin D; Zhang L; Shen H; Deng HW
G3 (Bethesda); 2017 Jul; 7(7):2271-2279. PubMed ID: 28500050
[TBL] [Abstract][Full Text] [Related]
7. Identifying candidate drivers of drug response in heterogeneous cancer by mining high throughput genomics data.
Nabavi S
BMC Genomics; 2016 Aug; 17(1):638. PubMed ID: 27526849
[TBL] [Abstract][Full Text] [Related]
8. CNAmet: an R package for integrating copy number, methylation and expression data.
Louhimo R; Hautaniemi S
Bioinformatics; 2011 Mar; 27(6):887-8. PubMed ID: 21228048
[TBL] [Abstract][Full Text] [Related]
9. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
Sintupisut N; Liu PL; Yeang CH
Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
[TBL] [Abstract][Full Text] [Related]
10. Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach.
Zhang D; Chen P; Zheng CH; Xia J
Oncotarget; 2016 Jan; 7(4):4298-309. PubMed ID: 26735889
[TBL] [Abstract][Full Text] [Related]
11. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
[TBL] [Abstract][Full Text] [Related]
12. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
Kunkle B; Yoo C; Roy D
Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
[TBL] [Abstract][Full Text] [Related]
13. Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma.
Kling T; Ferrarese R; Ó hAilín D; Johansson P; Heiland DH; Dai F; Vasilikos I; Weyerbrock A; Jörnsten R; Carro MS; Nelander S
EBioMedicine; 2016 Oct; 12():72-85. PubMed ID: 27667176
[TBL] [Abstract][Full Text] [Related]
14. Identifying mutated driver pathways in cancer by integrating multi-omics data.
Wu J; Cai Q; Wang J; Liao Y
Comput Biol Chem; 2019 Jun; 80():159-167. PubMed ID: 30959272
[TBL] [Abstract][Full Text] [Related]
15. [Master regulators associated with poor prognosis in glioblastoma multiforme].
Kalya MP; Beisbarth T; Kel A
Biomed Khim; 2021 May; 67(3):201-212. PubMed ID: 34142527
[TBL] [Abstract][Full Text] [Related]
16. Insights into Impact of DNA Copy Number Alteration and Methylation on the Proteogenomic Landscape of Human Ovarian Cancer via a Multi-omics Integrative Analysis.
Song X; Ji J; Gleason KJ; Yang F; Martignetti JA; Chen LS; Wang P
Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S52-S65. PubMed ID: 31227599
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of different levels of genomic data for cancer clinical outcome prediction.
Kim D; Shin H; Song YS; Kim JH
J Biomed Inform; 2012 Dec; 45(6):1191-8. PubMed ID: 22910106
[TBL] [Abstract][Full Text] [Related]
18. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.
Zhang W; Wang SL
Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714
[TBL] [Abstract][Full Text] [Related]
19. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
[TBL] [Abstract][Full Text] [Related]
20. A systematic comparison of copy number alterations in four types of female cancer.
Kaveh F; Baumbusch LO; Nebdal D; Børresen-Dale AL; Lingjærde OC; Edvardsen H; Kristensen VN; Solvang HK
BMC Cancer; 2016 Nov; 16(1):913. PubMed ID: 27876019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
